{
    "moduleId": "module_20",
    "moduleTitle": "L2: Assessment Tools",
    "passingScore": 80,
    "questions": [
        {
            "id": "q20_1",
            "question": "When utilizing the Menopause Rating Scale (MRS) to track clinical progress, which three specific dimensions are evaluated to provide a total score?",
            "options": [
                "Vasomotor, Cognitive, and Metabolic",
                "Somatic, Psychological, and Urogenital",
                "Endocrine, Musculoskeletal, and Neurological",
                "Circadian, Inflammatory, and Digestive"
            ],
            "correctAnswer": 1,
            "explanation": "The MRS is a validated scale that categorizes symptoms into Somatic (hot flashes, heart palpitations), Psychological (depressive mood, irritability), and Urogenital (bladder problems, vaginal dryness) dimensions."
        },
        {
            "id": "q20_2",
            "question": "In Advanced Hormonal Mapping (DUTCH testing), why is the assessment of the 4-OH-E1 pathway considered critical for a Menopause Specialist?",
            "options": [
                "It represents the 'protective' pathway of estrogen metabolism",
                "It is the primary pathway for progesterone synthesis in the adrenals",
                "It is the 'reactive' pathway that can lead to DNA adducts and increased breast cancer risk",
                "It indicates the rate of testosterone-to-estrogen aromatization in adipose tissue"
            ],
            "correctAnswer": 2,
            "explanation": "The 4-hydroxy pathway (4-OH) is considered the most 'toxic' estrogen metabolite pathway as it can form quinones that damage DNA, unlike the 2-OH (protective) or 16-OH (proliferative) pathways."
        },
        {
            "id": "q20_3",
            "question": "A client presents with 'normal' LDL-C levels but a Triglyceride-to-HDL ratio of 3.8. Based on Lesson 3, how should a specialist interpret this metabolic marker?",
            "options": [
                "The client is at low cardiovascular risk due to normal LDL",
                "The client likely has high insulin sensitivity and low visceral fat",
                "The ratio indicates significant insulin resistance and a likely presence of small, dense LDL particles",
                "The ratio is only relevant if the client is also hypertensive"
            ],
            "correctAnswer": 2,
            "explanation": "A Tg/HDL ratio greater than 3.0 is a strong surrogate marker for insulin resistance and the presence of atherogenic small, dense LDL particles, which are common as estrogen declines."
        },
        {
            "id": "q20_4",
            "question": "According to the Estrobolome assessment (Lesson 5), what is the clinical implication of elevated fecal Beta-glucuronidase?",
            "options": [
                "It prevents the absorption of dietary phytoestrogens",
                "It deconjugates bound estrogen in the gut, allowing it to be reabsorbed into circulation",
                "It indicates a lack of fiber-degrading bacteria in the microbiome",
                "It accelerates the excretion of estrogen, leading to lower serum levels"
            ],
            "correctAnswer": 1,
            "explanation": "Beta-glucuronidase is an enzyme produced by certain gut bacteria that 'un-couples' estrogen from its carrier (glucuronic acid), leading to the reabsorption of estrogen (enterohepatic recirculation) rather than its excretion."
        },
        {
            "id": "q20_5",
            "question": "Which biometric marker is the most sensitive indicator of autonomic nervous system (ANS) strain and 'allostatic load' during the perimenopausal transition?",
            "options": [
                "Resting Heart Rate (RHR)",
                "Oxygen Saturation (SpO2)",
                "Heart Rate Variability (HRV)",
                "Respiratory Rate"
            ],
            "correctAnswer": 2,
            "explanation": "HRV reflects the balance between the sympathetic and parasympathetic nervous systems. A decline in HRV often precedes the onset of significant perimenopausal symptoms and indicates a reduced capacity to handle stress."
        },
        {
            "id": "q20_6",
            "question": "When analyzing body composition via DXA in a menopausal client, what specific shift in fat distribution is most predictive of 'Inflammaging'?",
            "options": [
                "Increase in Gynoid (hip/thigh) fat",
                "Decrease in subcutaneous peripheral fat",
                "Increase in the Android-to-Gynoid (A:G) ratio and Visceral Adipose Tissue (VAT)",
                "Loss of brown adipose tissue in the cervical region"
            ],
            "correctAnswer": 2,
            "explanation": "The shift from a pear-shape (gynoid) to an apple-shape (android) distribution, specifically the accumulation of VAT, is a primary driver of systemic inflammation and metabolic syndrome in menopause."
        },
        {
            "id": "q20_7",
            "question": "In the PHASE Scorecardâ„¢ (Lesson 8), what does the 'E' represent in the integrated synthesis of a client's status?",
            "options": [
                "Estrogen Levels",
                "Environmental & Lifestyle Load",
                "Exercise Frequency",
                "Emotional Regulation"
            ],
            "correctAnswer": 1,
            "explanation": "The PHASE Scorecard stands for Physiology, Hormones, Adipose/Metabolic, Sleep/Stress, and Environment/Lifestyle, providing a 360-degree view of the client."
        },
        {
            "id": "q20_8",
            "question": "A client reports severe 'brain fog' and memory lapses. Which validated tool is recommended in Lesson 4 for screening neuro-cognitive mood changes specifically in the menopausal context?",
            "options": [
                "The PHQ-9 for depression only",
                "The MOCA (Montreal Cognitive Assessment) or Greene Climacteric Scale (Psychological subscore)",
                "The GAD-7 for anxiety only",
                "The MMSE (Mini-Mental State Exam) only"
            ],
            "correctAnswer": 1,
            "explanation": "While several tools exist, the Greene Climacteric Scale is menopause-specific, and the MOCA is a sensitive tool for detecting the mild cognitive impairment often described as 'brain fog.'"
        },
        {
            "id": "q20_9",
            "question": "Why is saliva testing often preferred over a single blood draw for assessing cortisol in a perimenopausal client with sleep disturbances?",
            "options": [
                "Saliva measures total cortisol, whereas blood only measures bound cortisol",
                "Saliva allows for multiple collection points to map the Diurnal Cortisol Slope",
                "Saliva testing is more accurate for measuring synthetic hormones",
                "Blood draws are too painful for menopausal clients"
            ],
            "correctAnswer": 1,
            "explanation": "Saliva testing allows for non-invasive, multi-point collection (e.g., 4-5 times a day), which is necessary to visualize the circadian rhythm of cortisol (the diurnal slope) rather than a single static snapshot."
        },
        {
            "id": "q20_10",
            "question": "According to Lesson 3, which cardiovascular marker is now considered more predictive of risk in midlife women than the standard LDL-C measurement?",
            "options": [
                "Total Cholesterol",
                "Apolipoprotein B (ApoB)",
                "Fasting Glucose",
                "Uric Acid"
            ],
            "correctAnswer": 1,
            "explanation": "ApoB measures the total number of atherogenic particles (including LDL, VLDL, and IDL). In menopausal women, ApoB often rises even when LDL-C remains stable, making it a superior marker for actual plaque risk."
        }
    ]
}